Rifaximin 400 mg Tablets are a high-value, super-specialty antibiotic. Salvus Pharma is now offering an exclusive PCD Pharma franchise for our brand, Rizix 400, in Patna.
- The Problem: The Danger of Systemic Antibiotics in Liver Patients For patients with severe liver disease (e.g., Hepatic Encephalopathy), using a standard, systemic antibiotic can be dangerous. These drugs are absorbed into the bloodstream, putting further toxic load on an already compromised liver.
- The Solution: A Safer, Gut-Selective Antibiotic Rizix 400 (Rifaximin) is the definitive solution. It is a non-systemic, gut-selective antibiotic. This means it works only inside the gut to kill harmful bacteria and is not absorbed into the bloodstream. This high-safety profile makes it the undisputed drug of choice for hepatologists.
- The Opportunity: A Premium, High-Margin Niche This is your chance to partner with super-specialists. Rizix 400 is a premium, high-margin product with no generic competition. By securing the exclusive monopoly franchise in Patna, you become a key player in the high-value gastro/hepatology market, backed by Salvus Pharma's WHO-GMP quality.
Enter the Super-Specialty Market in Patna: To learn more about the Rifaximin 400 mg PCD franchise, contact Salvus Pharma today. Contact Us: Call +91 9888902349 or email marketing@salvuspharma.in.
